It’s not too late to submit a poster to the upcoming BioTherapeutics 2013 event! http://biotherapeutics2013.com/
Abstracts for poster presentation only can be submitted up to two weeks before the event. Please note that there will be a best poster prize.
Abstracts can be submitted to: abstracts@euroscicon.com
Where: This event will be held at the Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Hertforshire, SG12FX, UK.
What: These events will focus on the research, development and standardisation involved in creating new biotherapeutics. These events have CPD accreditation.
Who: People from biopharmaceutical, pharmaceutical, biotech and academic research institutions will be attending these events. To find out specifically who should be attending click on the day of interest.
Click on the link below for more information:
http://biotherapeutics2013.com/
Tags: AAV vectors, Affinity chromatography, Analysis, antibody, Antibody Discovery, Antibody Engineering, antibody purification, automation, Biobetter, biobetters, Biologicals, Biologics, biopharmaceutical, biopharmaceutical manufacturing processes, bioreactor, Biosimilar, Biosimilarity, Biosimilars, botulinum, Business Development Genomics, cell line, Cell line development, Cell line engineering, cell line selection, Characterisation, characterization, CHO, CHO cell lines, chromatography, CMC, Comparability, Contaminant, Cost, CTD, deimmunizaion, dendritic cells; nucleic acid Toll-like receptor agonists; tumour immunotherapy; C-type lectin receptors, Discovery Chemistry, domain, downstream processing, Downtream processing, drug delivery, Drug-delivery; Gene-Delivery, E.coli, enabling, endogenous genome, EU, Formulation Development, Fusion, Gene correction/modification, gene targeting, genetic algorithms, glycan, glycosylation, Growth Hormone, HIV, homologous recombination, hormones, human volunteers, Humoral immunity in cancer, IgE, IgG4, Immunoassay, Immunogenicity, immunomodulation, intradermal vaccination, Long Acting Biological, mAb effector functions, mAbs., Malaria; Vaccine; Antibody; Immunology, mammalian expression systems, mass spectrometry, Medical device, microbial, Molecular Biology and Chemistry, Molecular Discovery Research, Molecular Medicine, monoclonal antibodies, monoclonal antibody, Monocytes/macrophages, multi-product facility design, Nanoscale, new technologies, next generation biologics, NTA, nuclear medicine, PET, polishing, post-translational modifications, Process Development, process economics, Product registration, protein, Protein Aggregation, Protein Engineering, protein linking, protein therapeutics, radionuclide therapy, radionuclides, Regulatory, Regulatory Affairs, screening., Similarity, SPECT, stapling, T cells, technologies, therapeutic, Therapeutic antibodies, therapeutic protein production, Time, tolerization, Translational Research, university-industry collaboration, Vaccine, Vaccine delivery; Immunotherapy; Nanoparticles, Vaccines, validtaion, variants, virus
Follow Us!